Fed. Circ. Affirms Rejection Of Cancer Therapy Patent Claims
The Federal Circuit on Wednesday upheld the rejection of claims in a NantKwest Inc. application for a patent covering a type of cancer therapy, despite finding that a lower court made...To view the full article, register now.
Already a subscriber? Click here to view full article